Publications by authors named "G K Grunwald"
Importance: Poor medication adherence is common. Text messaging is increasingly used to change patient behavior but often not rigorously tested.
Objective: To compare different types of text messaging strategies with usual care to improve medication refill adherence among patients nonadherent to cardiovascular medications.
Importance: A composite score for guideline-directed medical therapy (GDMT) for patients with heart failure (HF) is associated with increased survival. Whether hospital performance according to a GDMT score is associated with a broader array of clinical outcomes at lower costs is unknown.
Objectives: To evaluate hospital variability in GDMT score at discharge, 90-day risk-standardized clinical outcomes and costs, and associations between hospital GDMT score and clinical outcomes and costs.
Background: The use of recommended heart failure (HF) medications has improved over time, but opportunities for improvement persist among women and at rural hospitals.
Objectives: This study aims to characterize national trends in performance in the use of guideline-recommended pharmacologic treatment for HF at U.S.
Background: Obesity comprises the single greatest reversible risk factor for obstructive sleep apnea (OSA). Despite the potential of lifestyle-based weight loss services to improve OSA severity and symptoms, these programs have limited reach. POWER is a pragmatic trial of a remote self-directed weight loss care among patients with OSA.
View Article and Find Full Text PDFArticle Synopsis
- The study compared the clinical characteristics and outcomes of people living with HIV (PLWH) undergoing percutaneous coronary intervention (PCI) to uninfected individuals, using data from the Veterans Affairs Clinical Assessment Program from 2009 to 2019.
- It found that while treatment strategies for coronary artery disease were similar between PLWH and controls, PLWH were younger, had fewer traditional risk factors, and less extensive heart disease, but faced a higher mortality risk.
- By 5 years post-PCI, PLWH had a 21% increased risk of mortality compared to controls, highlighting that better control of HIV does not negate poorer long-term survival outcomes.